126 related articles for article (PubMed ID: 36400336)
21. Serum levels of IgG antibodies against alpha-enolase are increased in patients with Behçet's disease and are associated with the severity of oral ulcer, erythrocyte sedimentation rates, and C-reactive protein.
Kang SE; Lee SJ; Lee JY; Yoo HJ; Park JK; Lee EY; Lee EB; Song YW
Clin Exp Rheumatol; 2017; 35 Suppl 108(6):67-74. PubMed ID: 28770703
[TBL] [Abstract][Full Text] [Related]
22. Primary Headache in Behçet's and Neuro-Behçet's Disease.
Beton OE; Yucesan C
Neurol India; 2022; 70(1):254-257. PubMed ID: 35263891
[TBL] [Abstract][Full Text] [Related]
23. Differential expression of suppressor of cytokine signalling proteins in Behçet's disease.
Hamedi M; Bergmeier LA; Hagi-Pavli E; Vartoukian SR; Fortune F
Scand J Immunol; 2014 Nov; 80(5):369-76. PubMed ID: 25207681
[TBL] [Abstract][Full Text] [Related]
24. Novel markers of endothelial dysfunction and inflammation in Behçet's disease patients with ocular involvement: epicardial fat thickness, carotid intima media thickness, serum ADMA level, and neutrophil-to-lymphocyte ratio.
Yuksel M; Yildiz A; Oylumlu M; Turkcu FM; Bilik MZ; Ekinci A; Elbey B; Tekbas E; Alan S
Clin Rheumatol; 2016 Mar; 35(3):701-8. PubMed ID: 25744156
[TBL] [Abstract][Full Text] [Related]
25. Expression of Th-17 and RORγt mRNA in Behçet's Disease.
Hamzaoui K; Bouali E; Ghorbel I; Khanfir M; Houman H; Hamzaoui A
Med Sci Monit; 2011 Apr; 17(4):CR227-34. PubMed ID: 21455110
[TBL] [Abstract][Full Text] [Related]
26. Coronary involvement in patients with Behçet's disease.
Chen H; Zhang Y; Li C; Wu W; Liu J; Zhang F; Zheng W
Clin Rheumatol; 2019 Oct; 38(10):2835-2841. PubMed ID: 31273636
[TBL] [Abstract][Full Text] [Related]
27. Decreased erythrocyte deformability in Behçet's disease.
Usküdar O; Erdem A; Demiroğlu H; Dikmenoğlu N
Clin Hemorheol Microcirc; 2005; 33(2):89-94. PubMed ID: 16151256
[TBL] [Abstract][Full Text] [Related]
28. Increased sucrose permeability in Behçet's disease.
Koc B; Aymelek S; Sonmez A; Yilmaz MI; Kocar H
Rheumatol Int; 2004 Nov; 24(6):347-50. PubMed ID: 14530866
[TBL] [Abstract][Full Text] [Related]
29. Determination of serum vascular endothelial growth factor (VEGF) and VEGF receptor levels with VEGF gene polymorphisms in patients with Behçet's uveitis.
Sertoglu E; Yücel Ç; Omma A; Hayran Y; Colak S; Sandıkçı SC; Durukan AH; Ozgurtas T
Adv Clin Exp Med; 2022 Mar; 31(3):231-240. PubMed ID: 34918882
[TBL] [Abstract][Full Text] [Related]
30. Parallel disease activity of Behçet's disease with renal and entero involvements: a case report.
Watanabe-Kusunoki K; Kato M; Oki Y; Shimizu T; Kusunoki Y; Furukawa S; Furukawa S; Kitakawa H; Sakai K
BMC Nephrol; 2021 Apr; 22(1):122. PubMed ID: 33827474
[TBL] [Abstract][Full Text] [Related]
31. Synovial lymphoid neogenetic factors in Behçet's synovitis: do they play a role in self-limiting and subacute course of arthritis?
Pay S; Musabak U; Simsek I; Erdem H; Pekel A; Sengul A; Dinc A
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S21-6. PubMed ID: 17949547
[TBL] [Abstract][Full Text] [Related]
32. Increased complexin-1 and decreased miR-185 expression levels in Behçet's disease with and without neurological involvement.
Uğurel E; Şehitoğlu E; Tüzün E; Kürtüncü M; Çoban A; Vural B
Neurol Sci; 2016 Mar; 37(3):411-6. PubMed ID: 26577184
[TBL] [Abstract][Full Text] [Related]
33. [Influence of steroid hormones on the production of two inflammatory markers, IL-12 and nitric oxide, in Behçet's disease].
Ahmedi ML; Belguendouz H; Messaoudene D; Mesbah-Amroun H; Terahi M; Lahlou-Boukoffa OS; Touil-Boukoffa C
J Fr Ophtalmol; 2016 Apr; 39(4):333-40. PubMed ID: 27021132
[TBL] [Abstract][Full Text] [Related]
34. CXCL10/CXCR3 axis is associated with disease activity and the development of mucocutaneous lesions in patients with Behçet's disease.
Lee SJ; Kang SE; Kang EH; Choi BY; Masek-Hammerman K; Syed J; Zhan Y; Neff-Phillips K; Park JK; Lee EY; Lee EB; Song YW
Sci Rep; 2017 Nov; 7(1):14720. PubMed ID: 29116188
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of Mean Platelet Volume in Patients With Behcet's Disease as an Indicator of Vascular Thrombosis.
Ataş H; Canpolat F; Eskioglu F
Arch Iran Med; 2018 Jun; 21(6):234-239. PubMed ID: 29940741
[TBL] [Abstract][Full Text] [Related]
36. Thrombin activatable fibrinolysis inhibitor in Behçet's disease.
Donmez A; Aksu K; Celik HA; Keser G; Cagirgan S; Omay SB; Inal V; Aydin HH; Tombuloglu M; Doganavsargil E
Thromb Res; 2005; 115(4):287-92. PubMed ID: 15668188
[TBL] [Abstract][Full Text] [Related]
37. Case of Behçet's disease complicated by oculomotor nerve palsy associated with internal carotid artery-posterior communicating artery aneurysm.
Yamaoka T; Murota H; Katayama I
J Dermatol; 2015 Mar; 42(3):315-7. PubMed ID: 25573207
[TBL] [Abstract][Full Text] [Related]
38. Serum angiostatin levels in patients with Behçet's disease: does angiogenesis play a role in the pathogenesis of Behçet's disease?
Keskin D; Keskin G; Inal A; Ozışık L
Acta Clin Belg; 2014 Aug; 69(4):246-50. PubMed ID: 25012748
[TBL] [Abstract][Full Text] [Related]
39. A metagenomic study of the gut microbiome in Behcet's disease.
Ye Z; Zhang N; Wu C; Zhang X; Wang Q; Huang X; Du L; Cao Q; Tang J; Zhou C; Hou S; He Y; Xu Q; Xiong X; Kijlstra A; Qin N; Yang P
Microbiome; 2018 Aug; 6(1):135. PubMed ID: 30077182
[TBL] [Abstract][Full Text] [Related]
40. The status of serum vitamin D in patients with active Behcet's disease compared with controls.
Khabbazi A; Rashtchizadeh N; Ghorbanihaghjo A; Hajialiloo M; Ghojazadeh M; Taei R; Kolahi S
Int J Rheum Dis; 2014 May; 17(4):430-4. PubMed ID: 24118939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
